Deals
Boehringer, AbbVie Said to Be in Cancer-Partnership Talks
- Multi-billion alliance could be announced as soon as this week
- Companies are expanding in oncology amid health M&A wave
This article is for subscribers only.
Boehringer Ingelheim GmbH, the closely held German drugmaker, is in talks with AbbVie Inc. about a significant partnership that could help the companies expand their cancer treatment businesses, people familiar with the discussions said.
The talks are advanced and an agreement may be announced as soon as this week, the people said, asking not to be identified because the deliberations are private. The oncology alliance could be worth multi-billions of dollars, one of the people said. No final decisions have been made and talks could still be delayed or fall apart, they said.